Home › Lung Cancer › California › Glendale
Lung Cancer clinical trials in Glendale, CA
4 studies for Lung Cancer are looking for participants at sites in and around Glendale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Oncura Health - Corporate (Central IDS & Regulatory Only), Glendale
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
RecruitingPhase 3
- Los Alamitos Hematology/Oncology Medical Group, Glendale
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Los Angeles Cancer Network, Glendale
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
RecruitingPhase 2
- OPN Healthcare, Inc., Glendale
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Arlington, VA40 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH36 studies
- Philadelphia, PA36 studies
Other studies in Glendale
- Major Depressive Disorder12 studies
- Non-Small Cell Lung Cancer9 studies
- Depression6 studies
- Cancer (all types)5 studies
- Obesity5 studies
- Breast Cancer4 studies
- Colorectal Cancer4 studies
- Metastatic Cancer3 studies
- Macular Edema3 studies
- Melanoma3 studies
- Coronary Artery Disease3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.